Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 13 results:
Author Title [ Type![(Desc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-desc.png)
Filters: Author is Theocharidou, Eleni [Clear All Filters]
Acute Coronary Syndrome in Patients With Inflammatory Bowel Diseases: The Plaque and the Thrombus..
Angiology. 68(10), 843-844.
(2017). Are patients with inflammatory bowel diseases at increased risk for cardiovascular disease?.
Clin Gastroenterol Hepatol. 12(12), 2134-5.
(2014). Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review..
Angiology. 65(4), 284-93.
(2014). Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure..
Liver Transpl. 18(4), 405-12.
(2012). Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience..
Hepatol Int. 8(1), 137-45.
(2014). Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis..
Dig Dis Sci. 64(6), 1686-1694.
(2019). The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study..
Curr Vasc Pharmacol. 11(5), 779-84.
(2013). Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseases..
J Crohns Colitis. 8(9), 936-44.
(2014). Management of portal hypertension in children with portal vein thrombosis..
J Pediatr Gastroenterol Nutr. 57(4), 419-25.
(2013). The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score..
Am J Gastroenterol. 109(4), 554-62.
(2014). Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis..
Lancet. 376(9756), 1916-22.
(2010).
(2011).
(2014).